Fritz et al. showed that advanced prostate carcinoma clinical biopsy samples display elevated SCD1 expression and that inhibition of SCD1 robustly inhibits prostate carcinoma xenograft growth [154]. This evidence concerns the gene SCD and prostate carcinoma.